Parsing placebo treatments: a response to Barnhill and Miller
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- The ethics of placebo treatments in clinical practice: a reply to Glackin
- Placebo treatments, informed consent and ‘the grip of a false picture’
- Deception, intention and clinical practice
- Ethics of placebo use in clinical practice: why we need to look beyond deontology
- The moral case for the clinical placebo
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
- Cyclooxygenase 2—implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives
- Pretending to care
- Variability in the Response to Cyclooxygenase Inhibitors
- Controversies and advances in non-steroidal anti-inflammatory drug (NSAID) analgesia in chronic pain management